As a comapny, Merck, Sharp and Dohme (MSD) are committed to medical and scientific research, focussing on the development of novel drugs which will meet significant unmet medical needs, including diabetes. Insight into diabetes continues to eveolve, with MSD having a robust clinical development programme. This scientific understanding has allowed MSD to develop research into novel mechanisms of action.

MSD is proud to partner and sponosr a number of patient organisations and charities in order to help improve the lives of people living with diabetes.

MSD recognises the need for and is proud to support initiatives targeting health inequalities and education around chronic conditions such as diabetes. Apnee Sehat has demonstrated significant success in this cause in a short period of time. MSD are proud to support this important initiative that meets a true need and makes a real difference to people's lives,